ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1240

A Minority of Patients Utilize Most of Healthcare Resources in Rheumatoid Arthritis, Psoriatic Arthritis, Juvenile Idiopathic Arthritis, and Axial Spondyloarthritis

Nina Mars1, Anne M Kerola2, Markku J Kauppi3,4, Outi Elonheimo5,6, Santeri Huvinen5,6 and Tuulikki Sokka-Isler7,8, 1University of Helsinki, Helsinki, Finland, 2Department of Internal Medicine, Päijät-Häme Central Hospital, Lahti, Finland, 3School of Medicine, University of Tampere, Tampere, Finland, 4Department of Rheumatology, Päijät-Häme Central Hospital, Lahti, Finland, 5Network of Academic Health Centres, Department of Medicine, University of Helsinki, Helsinki, Finland, 6FCG Finnish Consulting Group Ltd., Helsinki, Finland, 7Rheumatology, Jyvaskyla Central Hospital, Jyvaskyla, Finland, 8RAID working group for EULAR, Zurich, Switzerland

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: axial spondyloarthritis, Health care cost, juvenile idiopathic arthritis (JIA), psoriatic arthritis and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Health Services Research - Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Rheumatoid arthritis (RA) is associated with high healthcare costs, but little is known about how the costs compare to other chronic rheumatic diseases. We combined a large, population-based clinical dataset on patients at a rheumatology clinic with an administrative database in order to compare healthcare utilization in patients with rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, and axial spondyloarthritis.

Methods: The data is on the adult population of the City of Jyväskylä, Finland (population 135 000). Their primary care is delivered at the local healthcare centers, which rely on the Jyväskylä Central Hospital (JCH) when specialist treatment is needed. The rheumatic specialist care is served in the JCH rheumatology unit, where clinical data is systematically recorded in a structured digital database. Well-recorded administrative data with costs data in euros (€) from fiscal year 2014 includes information on all public healthcare visits to physicians and allied healthcare professionals, both in primary and specialty care. Also inpatient care is included. With the Kruskal-Wallis test, we compared costs associated with healthcare utilization for adult patients with RA, psoriatic arthritis (PsA), juvenile idiopatic arthritis (JIA), and patients with axial spondyloarthritis or spondyloarthropathies (AS+SpA). We recognized high healthcare utilizing proportions in each and explored their clinical characteristics.

Results: The cost distribution was similar in all studied diseases (p = 0.62), and the distribution was widest in RA. The cost distribution was similar also in women (p = 0.31) and in men (p = 0.59). In RA (n = 967), 9% utilizes as much as the remaining 91%. Corresponding figures are 9% and 91% for PsA (n = 190), 10% and 90% for AS+SpA (n = 257), and 16% and 84% for JIA (n = 102). The high healthcare utilizing proportions were characterized by lower functional capacity measured with HAQ index (0-3) and higher pain (VAS 0-100), as well as higher disease activity, measured with DAS28. In addition, a larger proportion of these patients had at some point received biologics compared to patients with lower utilization. Mental health disorders were common multimorbidities in all studied diseases, particularly in young adults, as cardiovascular multimorbidities were particularly prevalent in older age groups.

Conclusion: Healthcare utilization is similar for RA, PsA, JIA, and AS+SpA. Approximately one tenth of patients utilizes as much as the remaining 90%. Higher healthcare utilization is characterized by patient perceived health measures. To limit the costs caused by healthcare utilization, disease activity should be minimized, improving functional capacity with reducing HAQ and pain. Moreover, costs of active treatment might be saved by reducing the healthcare utilization.


Disclosure: N. Mars, None; A. M. Kerola, None; M. J. Kauppi, None; O. Elonheimo, Employee of FCG Finnish Consulting Group Ltd, 3; S. Huvinen, Employee of FCG Finnish Consulting Group Ltd, 3; T. Sokka-Isler, None.

To cite this abstract in AMA style:

Mars N, Kerola AM, Kauppi MJ, Elonheimo O, Huvinen S, Sokka-Isler T. A Minority of Patients Utilize Most of Healthcare Resources in Rheumatoid Arthritis, Psoriatic Arthritis, Juvenile Idiopathic Arthritis, and Axial Spondyloarthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/a-minority-of-patients-utilize-most-of-healthcare-resources-in-rheumatoid-arthritis-psoriatic-arthritis-juvenile-idiopathic-arthritis-and-axial-spondyloarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-minority-of-patients-utilize-most-of-healthcare-resources-in-rheumatoid-arthritis-psoriatic-arthritis-juvenile-idiopathic-arthritis-and-axial-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology